New combo treatment tested to shrink skin cancer before surgery
NCT ID NCT05594290
Summary
This study is testing whether a short, one-cycle course of combined chemotherapy and immunotherapy given before surgery can help treat Merkel cell carcinoma, a rare and aggressive skin cancer. It involves 36 adults with operable cancer who have not had prior systemic treatment. The main goal is to see if this approach can completely eliminate the cancer cells in the removed tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MERKEL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Milan, 20133, Italy
Conditions
Explore the condition pages connected to this study.